Heavy smoking, reduced olanzapine levels, and treatment effects: A case report

Chih Chiang Chiu, Mong Liang Lu, Ming Chyi Huang, Kun P. Chen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A 30-year-old schizophrenic male patient, a heavy smoker, was successfully treated with olanzapine 15 mg/d during hospitalization. His cigarette consumption increased rapidly from 12 to 80 cigarettes per day following his discharge. Ten days later, his delusion of persecution, levels of hostility, and aggressive behavior worsened, while the plasma levels of olanzapine concurrently decreased. Based on our observations of this case, we suggest that the reduced levels of plasma olanzapine and exacerbated clinical symptoms are closely related to the increased consumption of cigarettes. A possible explanation would be that heavy smoking induced cytochrome P4501A2, the major enzyme involved in olanzapine metabolism. Therefore, patients who smoke should be closely monitored for their cigarette consumption when the dosage of olanzapine is adjusted.

Original languageEnglish
Pages (from-to)579-581
Number of pages3
JournalTherapeutic Drug Monitoring
Volume26
Issue number5
DOIs
Publication statusPublished - Oct 2004

Fingerprint

olanzapine
Tobacco Products
Smoking
Plasmas
Therapeutics
Delusions
Hostility
Cytochromes
Metabolism
Smoke
Hospitalization
Enzymes

Keywords

  • Cytochrome P450
  • Olanzapine
  • Smoking
  • Therapeutic drug monitoring

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Health, Toxicology and Mutagenesis
  • Pharmacology (medical)
  • Public Health, Environmental and Occupational Health
  • Pharmacology
  • Toxicology

Cite this

Heavy smoking, reduced olanzapine levels, and treatment effects : A case report. / Chiu, Chih Chiang; Lu, Mong Liang; Huang, Ming Chyi; Chen, Kun P.

In: Therapeutic Drug Monitoring, Vol. 26, No. 5, 10.2004, p. 579-581.

Research output: Contribution to journalArticle

Chiu, Chih Chiang ; Lu, Mong Liang ; Huang, Ming Chyi ; Chen, Kun P. / Heavy smoking, reduced olanzapine levels, and treatment effects : A case report. In: Therapeutic Drug Monitoring. 2004 ; Vol. 26, No. 5. pp. 579-581.
@article{51711b0593054e8ea3146f47ee09cf4e,
title = "Heavy smoking, reduced olanzapine levels, and treatment effects: A case report",
abstract = "A 30-year-old schizophrenic male patient, a heavy smoker, was successfully treated with olanzapine 15 mg/d during hospitalization. His cigarette consumption increased rapidly from 12 to 80 cigarettes per day following his discharge. Ten days later, his delusion of persecution, levels of hostility, and aggressive behavior worsened, while the plasma levels of olanzapine concurrently decreased. Based on our observations of this case, we suggest that the reduced levels of plasma olanzapine and exacerbated clinical symptoms are closely related to the increased consumption of cigarettes. A possible explanation would be that heavy smoking induced cytochrome P4501A2, the major enzyme involved in olanzapine metabolism. Therefore, patients who smoke should be closely monitored for their cigarette consumption when the dosage of olanzapine is adjusted.",
keywords = "Cytochrome P450, Olanzapine, Smoking, Therapeutic drug monitoring",
author = "Chiu, {Chih Chiang} and Lu, {Mong Liang} and Huang, {Ming Chyi} and Chen, {Kun P.}",
year = "2004",
month = "10",
doi = "10.1097/00007691-200410000-00018",
language = "English",
volume = "26",
pages = "579--581",
journal = "Therapeutic Drug Monitoring",
issn = "0163-4356",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Heavy smoking, reduced olanzapine levels, and treatment effects

T2 - A case report

AU - Chiu, Chih Chiang

AU - Lu, Mong Liang

AU - Huang, Ming Chyi

AU - Chen, Kun P.

PY - 2004/10

Y1 - 2004/10

N2 - A 30-year-old schizophrenic male patient, a heavy smoker, was successfully treated with olanzapine 15 mg/d during hospitalization. His cigarette consumption increased rapidly from 12 to 80 cigarettes per day following his discharge. Ten days later, his delusion of persecution, levels of hostility, and aggressive behavior worsened, while the plasma levels of olanzapine concurrently decreased. Based on our observations of this case, we suggest that the reduced levels of plasma olanzapine and exacerbated clinical symptoms are closely related to the increased consumption of cigarettes. A possible explanation would be that heavy smoking induced cytochrome P4501A2, the major enzyme involved in olanzapine metabolism. Therefore, patients who smoke should be closely monitored for their cigarette consumption when the dosage of olanzapine is adjusted.

AB - A 30-year-old schizophrenic male patient, a heavy smoker, was successfully treated with olanzapine 15 mg/d during hospitalization. His cigarette consumption increased rapidly from 12 to 80 cigarettes per day following his discharge. Ten days later, his delusion of persecution, levels of hostility, and aggressive behavior worsened, while the plasma levels of olanzapine concurrently decreased. Based on our observations of this case, we suggest that the reduced levels of plasma olanzapine and exacerbated clinical symptoms are closely related to the increased consumption of cigarettes. A possible explanation would be that heavy smoking induced cytochrome P4501A2, the major enzyme involved in olanzapine metabolism. Therefore, patients who smoke should be closely monitored for their cigarette consumption when the dosage of olanzapine is adjusted.

KW - Cytochrome P450

KW - Olanzapine

KW - Smoking

KW - Therapeutic drug monitoring

UR - http://www.scopus.com/inward/record.url?scp=4744369704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744369704&partnerID=8YFLogxK

U2 - 10.1097/00007691-200410000-00018

DO - 10.1097/00007691-200410000-00018

M3 - Article

C2 - 15385843

AN - SCOPUS:4744369704

VL - 26

SP - 579

EP - 581

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

SN - 0163-4356

IS - 5

ER -